Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Articles Tagged "arcam"

GE Increases Shareholding in Arcam

by BONEZONE | Jan 2018

GE’s ownership stake in Arcam is now around 95%.... Read more »

Arcam EBM Expanding Into New Facility

by BONEZONE | Jan 2018

The Härryda, Sweden space will open in 1Q19 ... Read more »

Magnus René and Johan Brandt (CEO and CFO) Announce Plans to Leave Arcam

by BONEZONE | Dec 2017

René will remain with the company until June 3, 2018 or until a new CEO is named; Brandt will remain until April 30, 2018 or until a new CFO is named.... Read more »

Arcam EBM Spun from Arcam AB

by BONEZONE | Mar 2017

Arcam's EBM operations will be led by General Manager, Karl Lindblom.  ... Read more »

Update on AP&C's Second Powder Plant

by BONEZONE | Feb 2017

AP&C will be the first dedicated AM material manufacturer to have multiple production sites.... Read more »

GE to Develop Financing to Stimulate Growth in Additive Manufacturing

by BONEZONE | Jan 2017

The initiative supports access to 3D printing technology for multiple industrial markets.... Read more »

GE Concludes Offers for Arcam, Concept Laser

by BONEZONE | Dec 2016

The agreement allows for GE to take full ownership of Concept Laser over the next several years.... Read more »

GE to Acquire Stake in Concept Laser

by BONEZONE | Oct 2016

GE will acquire a 75% stake in Concept Laser, manufacturer of additive manufacturing machines.... Read more »

Arcam's AP&C Subsidiary to Build Second Powder Plant

by BONEZONE | Oct 2016

AP&C plans to invest up to CAD 31MM in this facility, creating 106 new jobs within the next three years.... Read more »

GE to Acquire Additive Manufacturing Companies Arcam and SLM

by BONEZONE | Sep 2016

GE plans to acquire Arcam and SLM Solutions, suppliers of additive manufacturing equipment, for US $1.4BB in cash.... Read more »

Materialise and Arcam Partner to Integrate Software and Metal 3D Printer

by BONEZONE | Sep 2015

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »

Arcam AP&C Installs 4th and 5th Atomization Reactors

by BONEZONE | Sep 2015

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »

Arcam Opens New U.S. Sales/Support Office in Massachusetts

by BONEZONE | Aug 2015

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »

Arcam Expands in The UK and Ireland With New Sales and Support Office in Warwick

by BONEZONE | Apr 2015

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »

Order for Five Arcam Q10 Systems from Lima Corporate

by BONEZONE | Dec 2014

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »

Arcam Acquires DiSanto Technology

by BONEZONE | Sep 2014

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »

Arcam Receives Order for Two Arcam Q10 Systems

by BONEZONE | Jun 2014

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »

Arcam Acquiring AP&C, Metallic Powder Supplier

by BONEZONE | Dec 2013

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »

Arcam is now ISO 9001:2008 Certified

by BONEZONE | Apr 2013

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »

Arcam Q10, a New EBM Generation for Industrial Production of Implants

by BONEZONE | Mar 2013

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »

Strategic Alliance between Arcam and DiSanto Technology to offer EBM-designed and Manufactured Medical Implants

by BONEZONE | Feb 2013

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »

Arcam and Oak Ridge National Laboratory Sign Cooperation Agreement

by BONEZONE | Jul 2012

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »

Arcam Admitted to Trading on NASDAQ OMX Stockholm

by BONEZONE | Jun 2012

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »